Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 18 | 2025 | 1723 | 1.790 |
Why?
|
| BRCA2 Protein | 5 | 2020 | 50 | 1.680 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2023 | 734 | 1.150 |
Why?
|
| BRCA1 Protein | 4 | 2020 | 58 | 1.140 |
Why?
|
| Genetic Variation | 3 | 2019 | 430 | 1.010 |
Why?
|
| Genetic Testing | 5 | 2023 | 91 | 0.740 |
Why?
|
| DNA Repair | 5 | 2021 | 198 | 0.710 |
Why?
|
| Quantitative Trait Loci | 7 | 2005 | 88 | 0.660 |
Why?
|
| Blood Pressure | 10 | 2005 | 666 | 0.630 |
Why?
|
| Mutation | 9 | 2025 | 1177 | 0.620 |
Why?
|
| Oncogenes | 1 | 2019 | 44 | 0.620 |
Why?
|
| Population Groups | 1 | 2019 | 59 | 0.580 |
Why?
|
| Genes, BRCA2 | 1 | 2018 | 12 | 0.560 |
Why?
|
| Puerto Rico | 14 | 2025 | 1413 | 0.550 |
Why?
|
| Neoplasms | 4 | 2023 | 1377 | 0.510 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 863 | 0.470 |
Why?
|
| Models, Biological | 1 | 2019 | 712 | 0.460 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 561 | 0.460 |
Why?
|
| DNA Methylation | 3 | 2024 | 403 | 0.430 |
Why?
|
| Chromosome Mapping | 12 | 2021 | 199 | 0.430 |
Why?
|
| Ovarian Neoplasms | 4 | 2022 | 415 | 0.410 |
Why?
|
| Prostatic Neoplasms | 4 | 2025 | 1092 | 0.410 |
Why?
|
| Rats, Inbred Dahl | 9 | 2005 | 33 | 0.410 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2013 | 4 | 0.410 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 22 | 0.400 |
Why?
|
| Genetics, Population | 4 | 2021 | 121 | 0.400 |
Why?
|
| Humans | 41 | 2025 | 43102 | 0.390 |
Why?
|
| Female | 29 | 2025 | 24698 | 0.340 |
Why?
|
| Child Day Care Centers | 1 | 2011 | 11 | 0.340 |
Why?
|
| Education | 1 | 2011 | 60 | 0.330 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 291 | 0.330 |
Why?
|
| Child Abuse | 1 | 2011 | 92 | 0.310 |
Why?
|
| Case-Control Studies | 7 | 2020 | 1285 | 0.310 |
Why?
|
| Chromosomes | 4 | 2005 | 43 | 0.290 |
Why?
|
| Receptors, Estrogen | 4 | 2025 | 183 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 968 | 0.260 |
Why?
|
| Middle Aged | 16 | 2025 | 12222 | 0.250 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2025 | 6 | 0.240 |
Why?
|
| Health Status Disparities | 2 | 2024 | 719 | 0.240 |
Why?
|
| Hypertension | 4 | 2005 | 835 | 0.240 |
Why?
|
| Alleles | 3 | 2021 | 352 | 0.240 |
Why?
|
| Phenylthiohydantoin | 1 | 2025 | 5 | 0.240 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2025 | 13 | 0.240 |
Why?
|
| Gene Frequency | 3 | 2015 | 206 | 0.230 |
Why?
|
| Latin America | 4 | 2022 | 55 | 0.230 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2025 | 35 | 0.230 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2005 | 30 | 0.230 |
Why?
|
| Tissue Array Analysis | 1 | 2025 | 80 | 0.230 |
Why?
|
| Benzamides | 1 | 2025 | 81 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 1 | 2025 | 121 | 0.220 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 423 | 0.210 |
Why?
|
| Aged | 12 | 2025 | 8214 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2005 | 140 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 213 | 0.210 |
Why?
|
| Genetic Markers | 8 | 2012 | 150 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 307 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 54 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 48 | 0.180 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 92 | 0.180 |
Why?
|
| Biological Clocks | 1 | 2021 | 52 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 41 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2020 | 4 | 0.160 |
Why?
|
| Animals, Congenic | 9 | 2005 | 11 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 139 | 0.160 |
Why?
|
| Skin Pigmentation | 1 | 2020 | 23 | 0.160 |
Why?
|
| Genetic Counseling | 4 | 2022 | 15 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 2676 | 0.160 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 374 | 0.160 |
Why?
|
| DNA Glycosylases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2005 | 27 | 0.160 |
Why?
|
| Male | 17 | 2025 | 23409 | 0.150 |
Why?
|
| Point Mutation | 1 | 2019 | 98 | 0.150 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 75 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2019 | 91 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 512 | 0.150 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 201 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 59 | 0.150 |
Why?
|
| Prognosis | 3 | 2020 | 861 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 178 | 0.140 |
Why?
|
| Florida | 3 | 2025 | 478 | 0.140 |
Why?
|
| CpG Islands | 3 | 2024 | 109 | 0.140 |
Why?
|
| Introns | 1 | 2018 | 79 | 0.140 |
Why?
|
| Adenoma | 1 | 2018 | 96 | 0.130 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2016 | 10 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2021 | 925 | 0.130 |
Why?
|
| Rats | 10 | 2005 | 3735 | 0.120 |
Why?
|
| Chromosomes, Mammalian | 3 | 2005 | 18 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2019 | 876 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 223 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 291 | 0.120 |
Why?
|
| Caribbean Region | 1 | 2015 | 79 | 0.120 |
Why?
|
| Quality of Life | 1 | 2020 | 616 | 0.110 |
Why?
|
| Minority Groups | 1 | 2020 | 690 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 706 | 0.110 |
Why?
|
| United States | 4 | 2022 | 5205 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2020 | 661 | 0.100 |
Why?
|
| Genotype | 2 | 2013 | 800 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2018 | 2544 | 0.100 |
Why?
|
| Risk Factors | 4 | 2017 | 3994 | 0.100 |
Why?
|
| Heterozygote | 1 | 2012 | 110 | 0.090 |
Why?
|
| Microsatellite Instability | 2 | 2025 | 48 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2012 | 863 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 455 | 0.090 |
Why?
|
| Adult | 8 | 2025 | 13872 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 495 | 0.090 |
Why?
|
| Complement C3 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2012 | 110 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2011 | 24 | 0.090 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2011 | 37 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 590 | 0.090 |
Why?
|
| Organizational Case Studies | 1 | 2011 | 31 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2012 | 145 | 0.080 |
Why?
|
| Indians, North American | 1 | 2013 | 192 | 0.080 |
Why?
|
| Evidence-Based Practice | 1 | 2011 | 50 | 0.080 |
Why?
|
| Animals | 11 | 2025 | 16992 | 0.080 |
Why?
|
| Logistic Models | 3 | 2022 | 1009 | 0.080 |
Why?
|
| DNA Damage | 1 | 2012 | 356 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 152 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 205 | 0.080 |
Why?
|
| Rats, Inbred Lew | 6 | 2005 | 20 | 0.080 |
Why?
|
| Endometriosis | 1 | 2011 | 83 | 0.080 |
Why?
|
| Phenotype | 3 | 2021 | 780 | 0.080 |
Why?
|
| Receptors, Progesterone | 2 | 2022 | 92 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 704 | 0.070 |
Why?
|
| Child | 2 | 2021 | 3443 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2021 | 760 | 0.070 |
Why?
|
| Mexico | 2 | 2021 | 298 | 0.060 |
Why?
|
| Aorta | 2 | 2005 | 198 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2012 | 502 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1067 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 5080 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1600 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2025 | 57 | 0.060 |
Why?
|
| Nitriles | 1 | 2025 | 81 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2025 | 70 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 56 | 0.060 |
Why?
|
| Health Promotion | 1 | 2011 | 704 | 0.050 |
Why?
|
| Reference Values | 1 | 2005 | 211 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 294 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2003 | 19 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 378 | 0.050 |
Why?
|
| Base Sequence | 1 | 2005 | 983 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2025 | 934 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 2853 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2022 | 20 | 0.050 |
Why?
|
| Peru | 1 | 2022 | 41 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 437 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 74 | 0.050 |
Why?
|
| Language | 1 | 2023 | 185 | 0.040 |
Why?
|
| Internet | 1 | 2023 | 236 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 84 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 49 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2020 | 127 | 0.040 |
Why?
|
| Mice | 3 | 2025 | 6644 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 257 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 293 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2018 | 32 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2018 | 34 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2018 | 28 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 667 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 1612 | 0.030 |
Why?
|
| Sex Factors | 1 | 2021 | 1028 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1063 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1546 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2157 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 490 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.030 |
Why?
|
| Genome | 2 | 2005 | 149 | 0.030 |
Why?
|
| Genome, Human | 1 | 2013 | 144 | 0.020 |
Why?
|
| Argentina | 1 | 2012 | 14 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 159 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 449 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 86 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2013 | 226 | 0.020 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2011 | 69 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 611 | 0.020 |
Why?
|
| Culture | 1 | 2012 | 172 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 88 | 0.010 |
Why?
|
| Lod Score | 1 | 2005 | 13 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 77 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 183 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 28 | 0.010 |
Why?
|
| Breeding | 1 | 2003 | 28 | 0.010 |
Why?
|
| Telemetry | 1 | 2003 | 14 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 195 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2003 | 35 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 310 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 128 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 135 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2002 | 44 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 170 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 151 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 440 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 429 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 372 | 0.010 |
Why?
|